Global Leader with 15 years of experience in Pharmaceutical Industry, specializing in Pricing and Market Access, driving successful commercialization of Oncology & Specialty Care innovations across key global markets. Expertise spans value-based pricing, marketing, evidence generation, launch and commercialization, GA and stakeholder engagement, ensuring therapies achieve sustainable market access and deliver meaningful impact to patients.

Proven ability to navigate complex healthcare systems, develop robust access strategies, and align cross-functional teams to optimize product positioning. Adept at shaping payer value narratives, integrating real-world evidence into access strategies, and leading high-level negotiations with global stakeholders.

Focused on bridging scientific innovation with market realities to maximize patient access, commercial success, and long-term healthcare sustainability.